Clinical Trials Directory

Trials / Unknown

UnknownNCT02846155

Gastric Preparation of Magnetic-controlled Capsule Endoscopy

Gastric Preparation of Magnetic-controlled Capsule Endoscopy: A Prospective, Single Blinded and Randomized Controlled Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
16 Years – 75 Years
Healthy volunteers
Accepted

Summary

By using three different Gastric Preparation of Magnetic-controlled Capsule Endoscopy, the investigators hope to find out the optimal gastric preparation plan.

Detailed description

It is a prospective, single-blind, randomized controlled trial. Patients who were conducted by Magnetic-controlled Capsule Endoscopy at Changhai Hospital will be randomly allocated into three different Gastric Preparation group before the procedure. It include clear water group which patient only drink 1000ml clear water before checking; simethicone group which patient drink 950ml clear water and 15ml simethicone before checking; simethicone combined with pronase group which patient drink 900ml lear water and 15ml simethicone and 20,000iu pronase before checking. The result were got from a relevant professional physician's blinded independent image-reading.

Conditions

Interventions

TypeNameDescription
OTHERclear waterthe patients just drink common clear water before Magnetic-controlled Capsule Endoscopy examination
DRUGsimethiconethe patients drink clear water and simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion) before Magnetic-controlled Capsule Endoscopy examination
DRUGsimethicone combined with pronasethe patients drink simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion),pronase granules(Deyou;Beijing Tide Pharmaceutical Co,China,containing 20,000iu pronase),and clear water before Magnetic-controlled Capsule Endoscopy examination

Timeline

Start date
2016-05-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-07-27
Last updated
2016-07-27

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02846155. Inclusion in this directory is not an endorsement.